Basic Information
RNALocate ID: | RLID:11001360 |
RNA Symbol: | hsa-miR-139-5p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-139-5p |
RNA ID: | miRBase:MIMAT0000250 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 24797360 |
Tissue/Cell Line: | Cerebrospinal fluid |
Method: | RNA sequencing |
Description: | Differentially expressed miRNAs detected in the cerebrospinal fluid (CSF). Data are collected from Table 1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001594 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:11001358 | Exosome | Plasma | 29323722 |
RLID:11001359 | Exosome | Plasma | 23663360 |
RLID-D:11000044 | Exosome | Blood | |
RLID-D:11000313 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-139-5p | Diffuse large b cell lymphoma | MNDR-E-MI-13088 |
MNDR | hsa-miR-139-5p | Splenic marginal zone lymphoma | MNDR-E-MI-13089 |
MNDR | hsa-miR-139-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-13090 |
MNDR | hsa-miR-139-5p | Oral squamous cell carcinoma | MNDR-E-MI-13091 |
MNDR | hsa-miR-139-5p | Large cell neuroendocrine cancer | MNDR-E-MI-13092 |
MNDR | hsa-miR-139-5p | Follicular lymphoma | MNDR-E-MI-13093 |
MNDR | hsa-miR-139-5p | Medulloblastoma | MNDR-E-MI-13094 |
MNDR | hsa-miR-139-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-13095 |
MNDR | hsa-miR-139-5p | Lymphoma | MNDR-E-MI-13096 |
MNDR | hsa-miR-139-5p | Lymphoma non-hodgkin | MNDR-E-MI-13097 |
MNDR | hsa-miR-139-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-13098 |
MNDR | hsa-miR-139-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-13099 |
MNDR | hsa-miR-139-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-13100 |
MNDR | hsa-miR-139-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-13101 |
MNDR | hsa-miR-139-5p | Her2-receptor positive breast cancer | MNDR-E-MI-13102 |
MNDR | hsa-miR-139-5p | Breast cancer luminal | MNDR-E-MI-13103 |
MNDR | hsa-miR-139-5p | Prostate cancer | MNDR-E-MI-13104 |
MNDR | hsa-miR-139-5p | Gastric cancer | MNDR-E-MI-13105 |
MNDR | hsa-miR-139-5p | Gastric lymphoma | MNDR-E-MI-13106 |
MNDR | hsa-miR-139-5p | Alzheimer disease | MNDR-E-MI-13107 |
MNDR | hsa-miR-139-5p | Intracranial aneurysm | MNDR-E-MI-13108 |
MNDR | hsa-miR-139-5p | Bladder cancer | MNDR-E-MI-13109 |
MNDR | hsa-miR-139-5p | Esophageal carcinoma | MNDR-E-MI-13110 |
MNDR | hsa-miR-139-5p | Dysautonomia familial | MNDR-E-MI-13111 |
MNDR | hsa-miR-139-5p | Head and neck cancer | MNDR-E-MI-13112 |
MNDR | hsa-miR-139-5p | Primary biliary cirrhosis | MNDR-E-MI-13113 |
MNDR | hsa-miR-139-5p | Huntington disease | MNDR-E-MI-13114 |
MNDR | hsa-miR-139-5p | Chorea | MNDR-E-MI-13115 |
MNDR | hsa-miR-139-5p | Cardiovascular disease | MNDR-E-MI-13116 |
MNDR | hsa-miR-139-5p | Carotid stenosis | MNDR-E-MI-13117 |
MNDR | hsa-miR-139-5p | Uterine fibroid | MNDR-E-MI-13118 |
MNDR | hsa-miR-139-5p | Lung cancer | MNDR-E-MI-13119 |
MNDR | hsa-miR-139-5p | Endometrial cancer | MNDR-E-MI-13120 |
MNDR | hsa-miR-139-5p | Down syndrome | MNDR-E-MI-13121 |
MNDR | hsa-miR-139-5p | Parkinson disease | MNDR-E-MI-13122 |
MNDR | hsa-miR-139-5p | Basal-like breast cancer | MNDR-E-MI-13123 |
MNDR | hsa-miR-139-5p | Neuroendocrine neoplasia | MNDR-E-MI-13124 |
MNDR | hsa-miR-139-5p | Pituitary neoplasms | MNDR-E-MI-13125 |
MNDR | hsa-miR-139-5p | Pancreatic cancer | MNDR-E-MI-13126 |
MNDR | hsa-miR-139-5p | Melanoma | MNDR-E-MI-13127 |
MNDR | hsa-miR-139-5p | Rectum adenocarcinoma | MNDR-E-MI-13128 |
MNDR | hsa-miR-139-5p | Nephroblastoma | MNDR-E-MI-13129 |
MNDR | hsa-miR-139-5p | Colon cancer | MNDR-E-MI-13130 |
MNDR | hsa-miR-139-5p | Colon adenocarcinoma | MNDR-E-MI-13131 |
MNDR | hsa-miR-139-5p | Familial ovarian cancer | MNDR-E-MI-13132 |
MNDR | hsa-miR-139-5p | Basal cell carcinoma | MNDR-E-MI-13133 |
MNDR | hsa-miR-139-5p | Prostate adenocarcinoma | MNDR-E-MI-13134 |
MNDR | hsa-miR-139-5p | Carcinoma ductal breast | MNDR-E-MI-13135 |
MNDR | hsa-miR-139-5p | Glioblastoma | MNDR-E-MI-13136 |
MNDR | hsa-miR-139-5p | Astrocytoma | MNDR-E-MI-13137 |
MNDR | hsa-miR-139-5p | Glioma | MNDR-E-MI-13138 |
MNDR | hsa-miR-139-5p | Oligodendroglioma | MNDR-E-MI-13139 |
MNDR | hsa-miR-139-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-13140 |
MNDR | hsa-miR-139-5p | Osteosarcoma | MNDR-E-MI-13141 |
MNDR | hsa-miR-139-5p | Breast carcinoma | MNDR-E-MI-13142 |
MNDR | hsa-miR-139-5p | Middle cerebral artery infarction | MNDR-E-MI-13143 |
MNDR | hsa-miR-139-5p | Uterine cancer | MNDR-E-MI-13144 |
MNDR | hsa-miR-139-5p | Gastric adenocarcinoma | MNDR-E-MI-13145 |
MNDR | hsa-miR-139-5p | Cervical squamous cell carcinoma | MNDR-E-MI-13146 |
MNDR | hsa-miR-139-5p | Pituitary adenoma | MNDR-E-MI-13147 |
MNDR | hsa-miR-139-5p | Lung squamous cell carcinoma | MNDR-E-MI-13148 |
MNDR | hsa-miR-139-5p | Carcinoma lung non-small-cell | MNDR-E-MI-13149 |
MNDR | hsa-miR-139-5p | Lung adenocarcinoma | MNDR-E-MI-13150 |
MNDR | hsa-miR-139-5p | Adrenocortical carcinoma | MNDR-E-MI-13151 |
MNDR | hsa-miR-139-5p | Adrenal cortical carcinoma | MNDR-E-MI-13152 |
MNDR | hsa-miR-139-5p | Thyroid carcinoma | MNDR-E-MI-13153 |
MNDR | hsa-miR-139-5p | Bladder urothelial carcinoma | MNDR-E-MI-13154 |
MNDR | hsa-miR-139-5p | Pancreatic adenocarcinoma | MNDR-E-MI-13155 |
MNDR | hsa-miR-139-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-13156 |
MNDR | hsa-miR-139-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-13157 |
MNDR | hsa-miR-139-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-13158 |
MNDR | hsa-miR-139-5p | Clear cell renal cell carcinoma | MNDR-E-MI-13159 |
MNDR | hsa-miR-139-5p | Allergic rhinitis | MNDR-E-MI-13160 |
MNDR | hsa-miR-139-5p | Large cell carcinoma | MNDR-E-MI-13161 |
MNDR | hsa-miR-139-5p | Cholangiocarcinoma | MNDR-E-MI-13162 |
MNDR | hsa-miR-139-5p | Gallbladder carcinoma | MNDR-E-MI-13163 |
MNDR | hsa-miR-139-5p | Esophageal cancer | MNDR-E-MI-13164 |
MNDR | hsa-miR-139-5p | Liver cirrhosis | MNDR-E-MI-13165 |
MNDR | hsa-miR-139-5p | Lung small cell carcinoma | MNDR-E-MI-13166 |
MNDR | hsa-miR-139-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-13167 |
MNDR | hsa-miR-139-5p | Breast invasive carcinoma | MNDR-E-MI-13168 |
MNDR | hsa-miR-139-5p | Early hepatocellular carcinoma | MNDR-E-MI-13169 |
MNDR | hsa-miR-139-5p | Familiar ovarian carcinoma | MNDR-E-MI-13170 |
MNDR | hsa-miR-139-5p | B-cell lymphoma | MNDR-E-MI-13171 |
MNDR | hsa-miR-139-5p | Rheumatoid arthritis | MNDR-E-MI-13172 |
MNDR | hsa-miR-139-5p | T-cell leukemia | MNDR-E-MI-13173 |
MNDR | hsa-miR-139-5p | Malignant pleural mesothelioma | MNDR-E-MI-13174 |
MNDR | hsa-miR-139-5p | Barrett's adenocarcinoma | MNDR-E-MI-13175 |
MNDR | hsa-miR-139-5p | Chronic myeloid leukemia | MNDR-E-MI-13176 |
MNDR | hsa-miR-139-5p | Hodgkin lymphoma | MNDR-E-MI-13177 |
MNDR | hsa-miR-139-5p | Burkitt lymphoma | MNDR-E-MI-13178 |
MNDR | hsa-miR-139-5p | Neuromyelitis optica | MNDR-E-MI-13179 |
MNDR | hsa-miR-139-5p | Skin cutaneous melanoma | MNDR-E-MI-13180 |
MNDR | hsa-miR-139-5p | Skin melanoma | MNDR-E-MI-13181 |
MNDR | hsa-miR-139-5p | Acute myelogenous leukemia | MNDR-E-MI-13182 |
MNDR | hsa-miR-139-5p | Colorectal cancer | MNDR-E-MI-13183 |
MNDR | hsa-miR-139-5p | Nasopharyngeal carcinoma | MNDR-E-MI-13184 |
MNDR | hsa-miR-139-5p | Ependymoma | MNDR-E-MI-13185 |
MNDR | hsa-miR-139-5p | Cardiomegaly | MNDR-E-MI-13186 |
MNDR | hsa-miR-139-5p | Prostatic neoplasms | MNDR-E-MI-13187 |
MNDR | hsa-miR-139-5p | Sleep deprivation | MNDR-E-MI-13188 |
MNDR | hsa-miR-139-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-13189 |
MNDR | hsa-miR-139-5p | Barrett's carcinogenesis | MNDR-E-MI-13190 |
MNDR | hsa-miR-139-5p | Breast cancer her3+ negative | MNDR-E-MI-13191 |
MNDR | hsa-miR-139-5p | Cardiac fibrosis | MNDR-E-MI-13192 |
MNDR | hsa-miR-139-5p | Duke A | MNDR-E-MI-13193 |
MNDR | hsa-miR-139-5p | Low grade dysplastic nodule | MNDR-E-MI-13194 |
MNDR | hsa-miR-139-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-13195 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ACTC1 | Homo sapiens | RR00037075 |
TOP